Immunological markers in allergic rhinitis patients treated with date palm immunotherapy

Inflammation Research

Volumn 61, Issue 7, 2012, Pages 719-724

  Boghdadi, Ghada ^a   Marei, Ayman ^a   Ali, Atef ^b   Lotfy, Gamal ^b   Abdulfattah, Magdi ^b   Sorour, Samir ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Allergic rhinitis; Date palm (Phoenix dactylifera); IFN ; IL 10

Indexed keywords

ALBUMIN; ANTIHISTAMINIC AGENT; BIOLOGICAL MARKER; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; PHOENIX DACTYLIFERA EXTRACT; PLANT EXTRACT; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALBUMIN BLOOD LEVEL; ALLERGIC RHINITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DATE (FRUIT); FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAINTENANCE DRUG DOSE; MALE; MAXIMUM TOLERATED DOSE; NOSE MUCOSA; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ALBUMINS; ALLERGENS; ARECACEAE; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; NASAL MUCOSA; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; YOUNG ADULT;

EID: 84865115548     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0464-4     Document Type: Article

References (26)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl 5):S147-334.
2. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schunemann HJ. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3): 466-76.
3. Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2010;2:65-76.
4. Leung DY. Immunologic basis of chronic allergic diseases: clinical messages from the laboratory bench. Pediatr Res. 1997;42(5):559-68. (Pubitemid 27459458)
5. Ng ML, Warlow RS, Chrishanthan N, Ellis C, Walls RS. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (II). Clin Exp Allergy. 2000;30(10):1417-22.
6. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol. 2007;119(4):881-91. (Pubitemid 46527840)
7. Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Vaccine. 2007; 25(5):957-64. (Pubitemid 44873157)
8. Jayasekera NP, Toma TP, Williams A, Rajakulasingam K. Mechanisms of immunotherapy in allergic rhinitis. Biomed Pharmacother. 2007;61(1):29-33. (Pubitemid 46185879)
9. Wilson DR, Irani AM, Walker SM, Jacobson MR, Mackay IS, Schwartz LB, Durham SR. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy. 2001;31(11):1705-13. (Pubitemid 34204427)
10. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, Kay AB, Durham SR. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest. 1993;92(2):644-51. (Pubitemid 23262381)
11. Marcucci F, Sensi L, Di Cara G, Incorvaia C, Puccinelli P, Scurati S, Frati F. Which allergen extract for grass pollen immunotherapy? An in vitro study. Immunol Invest. 2010;39(6): 635-44.
12. Kwaasi AA, Harfi HA, Parhar RS, Al-Sedairy ST, Collison KS, Panzani RC, Al-Mohanna FA. Allergy to date fruits: characterization of antigens and allergens of fruits of the date palm (Phoenix dactylifera L.). Allergy. 1999;54(12):1270-7. (Pubitemid 30070313)
13. Postigo I, Guisantes JA, Negro JM, Rodriguez-Pacheco R, David- Garcia D, Martinez J. Identification of 2 new allergens of Phoenix dactylifera using an immunoproteomics approach. J Invest Allergol Clin Immunol. 2009;19(6):504-7.
14. Schatz M, Meltzer EO, Nathan R, Derebery MJ, Mintz M, Stanford RH, Dalal AA, Silvey MJ, Kosinski M. Psychometric validation of the rhinitis control assessment test: a brief patientcompleted instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol. 2010;104(2):118-24.
15. Krouse JH, Mabry RL. Skin testing for inhalant allergy 2003: current strategies. Otolaryngol Head Neck Surg. 2003;129(4 Suppl):S33-49. (Pubitemid 37248940)
16. Maezawa Y, Nakajima H, Seto Y, Suto A, Kumano K, Kubo S, Karasuyama H, Saito Y, Iwamoto I. IgE-dependent enhancement of Th2 cell-mediated allergic inflammation in the airways. Clin Exp Immunol. 2004;135(1):12-8. (Pubitemid 38067922)
17. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol. 1992;148(7):2142-7.
18. Worm M, Henz BM. Molecular regulation of human IgE synthesis. J Mol Med. 1997;75(6):440-7. (Pubitemid 27297014)
19. Prescott SL. New concepts of cytokines in asthma: is the Th2/Th1 paradigm out the window? J Paediatr Child Health. 2003;39(8): 575-9. (Pubitemid 37463938)
20. Robinson DS, Tsicopoulos A, Meng Q, Durham S, Kay AB, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol. 1996;14(2):113-7. (Pubitemid 126441382)
21. Magnan A, van Pee D, Bongrand P, Vervloet D. Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy. 1998;53(11):1092-5. (Pubitemid 28539574)
22. Kosaka S, Tamauchi H, Terashima M, Maruyama H, Habu S, Kitasato H. IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation. Immunobiology. 2010;216:811-20.
23. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev. 2004;202:175-90. (Pubitemid 39576912)
24. Mo JH, Kang EK, Quan SH, Rhee CS, Lee CH, Kim DY. Antitumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model. Allergy. 2011;66(2):279-86.
25. Iwasaki M, Saito K, Takemura M, Sekikawa K, Fujii H, Yamada Y, Wada H, Mizuta K, Seishima M, Ito Y. TNF-alpha contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol. 2003;112(1):134-40. (Pubitemid 36819818)
26. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 2001;107(1): 87-93. (Pubitemid 32105250)